Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 59
2021 79
2022 23
2023 11
2024 10
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk RA, Bartoszko JJ, Zeraatkar D, Kum E, Qasim A, Martinez JPD, Izcovich A, Lamontagne F, Han MA, Agarwal A, Agoritsas T, Azab M, Bravo G, Chu DK, Couban R, Devji T, Escamilla Z, Foroutan F, Gao Y, Ge L, Ghadimi M, Heels-Ansdell D, Honarmand K, Hou L, Ibrahim Q, Khamis A, Lam B, Mansilla C, Loeb M, Miroshnychenko A, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Pardo-Hernandez H, Rada G, Rizwan Y, Saadat P, Switzer C, Thabane L, Tomlinson G, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Zhao Y, Guyatt GH, Brignardello-Petersen R. Siemieniuk RA, et al. BMJ. 2020 Jul 30;370:m2980. doi: 10.1136/bmj.m2980. BMJ. 2020. Update in: BMJ. 2020 Sep 11;370:m3536. doi: 10.1136/bmj.m3536. Update in: BMJ. 2020 Dec 17;371:m4852. doi: 10.1136/bmj.m4852. Update in: BMJ. 2021 Mar 31;372:n858. doi: 10.1136/bmj.n858. PMID: 32732190 Free PMC article. Updated.
OBJECTIVE: To compare the effects of treatments for coronavirus disease 2019 (covid-19). DESIGN: Living systematic review and network meta-analysis. DATA SOURCES: WHO covid-19 database, a comprehensive multilingual source of global cov …
OBJECTIVE: To compare the effects of treatments for coronavirus disease 2019 (covid-19). DESIGN: Living systematic review and …
"Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.".
Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):589-596. doi: 10.1016/j.dsx.2020.05.017. Epub 2020 May 12. Diabetes Metab Syndr. 2020. PMID: 32417708 Free PMC article.
BACKGROUNDS AND AIMS: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase pol …
BACKGROUNDS AND AIMS: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied …
The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
Shamshirian A, Hessami A, Heydari K, Navaei RA, Ebrahimzadeh MA, Yip GW, Ghasemian R, Sedaghat M, Baradaran H, Yazdi SM, Aboufazeli E, Jafarpour H, Dadgostar E, Tirandazi B, Sadeghnezhad R, Karimifar K, Eftekhari A, Shamshirian D. Shamshirian A, et al. Ann Acad Med Singap. 2020 Oct;49(10):789-800. Ann Acad Med Singap. 2020. PMID: 33283842 Free article.
OBJECTIVE: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19. ...Meta-regression analysis showed that age was the factor that significantly affected mortality (P&lt …
OBJECTIVE: A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the …
Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials.
Amani B, Khanijahani A, Amani B. Amani B, et al. Sci Rep. 2021 Jun 7;11(1):11974. doi: 10.1038/s41598-021-91089-3. Sci Rep. 2021. PMID: 34099745 Free PMC article.
The efficacy and safety of Hydroxychloroquine (HCQ) in treating coronavirus disease (COVID-19) is disputed. This systematic review and meta-analysis aimed to examine the efficacy and safety of HCQ in addition to standard of care (SOC) in COVI …
The efficacy and safety of Hydroxychloroquine (HCQ) in treating coronavirus disease (COVID-19) is disputed. This system …
Hydroxychloroquine for Non-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Lucchetta R, Matuoka JY, Oliveira Junior HA, Oliveira G, Cavalcanti AB, Azevedo L, Berwanger O, Lopes RD, Rosa RG, Veiga VC, Avezum Á. Lucchetta R, et al. Arq Bras Cardiol. 2023 Apr 7;120(4):e20220380. doi: 10.36660/abc.20220380. eCollection 2023. Arq Bras Cardiol. 2023. PMID: 37042856 Free PMC article. English, Portuguese.
BACKGROUND: Previous systematic reviews have identified no benefit of hydroxychloroquine and chloroquine in non-hospitalized COVID-19 patients. After publication of these reviews, the results of COPE, the largest randomized trial conducted to date, became ava …
BACKGROUND: Previous systematic reviews have identified no benefit of hydroxychloroquine and chloroquine in non-hospitalized COVID …
Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
García-Albéniz X, Del Amo J, Polo R, Morales-Asencio JM, Hernán MA. García-Albéniz X, et al. Eur J Epidemiol. 2022 Aug;37(8):789-796. doi: 10.1007/s10654-022-00891-4. Epub 2022 Aug 9. Eur J Epidemiol. 2022. PMID: 35943669 Free PMC article.
BACKGROUND: Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention of COVID-19 has been adversely affected by a widespread conviction that HCQ is not effective for prevention. In the absence of an updated systematic review, we conducted …
BACKGROUND: Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention of COVID-19 has been adversel …
Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients.
Yang TH, Chou CY, Yang YF, Chien CS, Yarmishyn AA, Yang TY, Liu CH, Chang KJ, Yang YP, Chang YL. Yang TH, et al. J Chin Med Assoc. 2021 Feb 1;84(2):233-241. doi: 10.1097/JCMA.0000000000000425. J Chin Med Assoc. 2021. PMID: 32947506 Free PMC article.
BACKGROUND: Since COVID-19 outbreak, hydroxychloroquine (HCQ) has been tested for effective therapies, and the relevant researches have shown controversial results. ...Accordingly, more rigorous, large-scale, and long follow-up period studies in patients with …
BACKGROUND: Since COVID-19 outbreak, hydroxychloroquine (HCQ) has been tested for effective therapies, and the relevant …
A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19.
Hussain N, Chung E, Heyl JJ, Hussain B, Oh MC, Pinon C, Boral S, Chun D, Babu B. Hussain N, et al. Cureus. 2020 Aug 24;12(8):e10005. doi: 10.7759/cureus.10005. Cureus. 2020. PMID: 32983702 Free PMC article.
Introduction Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world with a large medical and economic impact. ...This meta-analysis was performed to assess the effects of …
Introduction Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly sprea …
Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
Zang Y, Han X, He M, Shi J, Li Y. Zang Y, et al. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):775-782. doi: 10.1007/s00210-020-01964-5. Epub 2020 Sep 6. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 32892293 Free PMC article.
Hydroxychloroquine (HCQ) has been implicated in antiviral activity in vitro against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ...Death (RR = 1.92, 95% CI = 1.26-2.93, P = 0.003) was distinctly different in HCQ group compared …
Hydroxychloroquine (HCQ) has been implicated in antiviral activity in vitro against severe acute respiratory syndrome coronavirus …
Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
Moraes VY, Marra AR, Matos LL, Serpa Neto A, Rizzo LV, Cendoroglo Neto M, Lenza M. Moraes VY, et al. Einstein (Sao Paulo). 2022 Dec 2;20:eRW0045. doi: 10.31744/einstein_journal/2022RW0045. eCollection 2022. Einstein (Sao Paulo). 2022. PMID: 36477526 Free PMC article.
OBJECTIVE: We performed a systematic review of the literature and meta-analysis on the efficacy and safety of hydroxychloroquine to treat COVID-19 patients. ...CONCLUSION: Hydroxychloroquine is not efficacious in reducing mortality of …
OBJECTIVE: We performed a systematic review of the literature and meta-analysis on the efficacy and safety of hydroxychloro …
164 results